Inventor · disambiguated record
Ivan Zlatev
Also filed as: ZLATEV IVAN
11 granted patents·15 pending applications·155 citations·filing 2009–2025
88Inventor score
Files withALNYLAM PHARMACEUTICALS INC19MANOHARAN MUTHIAH4LACKEY JEREMY1PRAKASH THAZHA P1ZLATEV IVAN1
Top patents by PatentIndex Score
26 records- 0197US8927513B25′ phosphate mimicsMANOHARAN MUTHIAH·Filed 2010·Granted Jan 6, 2015·108 cites·14 claims
- 0294US9156873B2Modified 5′ diphosphate nucleosides and oligomeric compounds prepared therefromPRAKASH THAZHA P·Filed 2011·Granted Oct 13, 2015·19 cites·20 claims
- 0393US10119136B2RNAi agents modified at the 4′-C positionALNYLAM PHARMACEUTICALS INC·Filed 2015·Granted Nov 6, 2018·10 cites·18 claims
- 0488US9725479B25′-end derivativesMANOHARAN MUTHIAH·Filed 2011·Granted Aug 8, 2017·12 cites·15 claims
- 0585US2025236871A1Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0678US10131908B25′ phosphate mimicsALNYLAM PHARMACEUTICALS INC·Filed 2014·Granted Nov 20, 2018·3 cites·17 claims
- 0776US12241064B2REVERSIR™ compoundsALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Mar 4, 2025·0 cites·25 claims
- 0876US2025059536A1Tunable reversir tm compoundsALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0974US12221607B2Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2021·Granted Feb 11, 2025·0 cites·24 claims
- 1073US12018260B2Tunable Reversir™ compoundsALNYLAM PHARMACEUTICALS INC·Filed 2022·Granted Jun 25, 2024·0 cites·19 claims
- 1173US9035041B2Process for triphosphate oligonucleotide synthesisZLATEV IVAN·Filed 2009·Granted May 19, 2015·3 cites·21 claims
- 1269US2025257351A1Reversir tm compoundsALNYLAM PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1368US2025304957A1Single-stranded loop oligonucleotidesALNYLAM PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1467US2022177885A1Endosomal cleavable linkersALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1566US2024360455A1Extra-hepatic delivery irna compositions and methods of use thereofALNYLAM PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1663US11053495B2Multi-targeted single entity conjugatesALNYLAM PHARMACEUTICALS INC·Filed 2016·Granted Jul 6, 2021·0 cites·13 claims
- 1761US2012107272A1Synthetic methods and derivatives of triphosphate oligonucleotidesMANOHARAN MUTHIAH·Filed 2009·Application pending·0 cites
- 1861US2025075217A1Peptide ligands for cns and ocular delivery of rnai compoundsALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1959US2024336914A12'-modified nucleoside based oligonucleotide prodrugsALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2058US2025270562A1Bis-rnai compounds for cns deliveryALNYLAM PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2157US2017369872A1Reversir tm compoundsALNYLAM PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2254US2023257745A1Circular siRNAsALNYLAM PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2352US2023016929A1Extrahepatic deliveryALNYLAM PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2450US11286482B2Endosomal cleavable linkersALNYLAM PHARMACEUTICALS INC·Filed 2018·Granted Mar 29, 2022·0 cites·19 claims
- 2539US2013260460A1Conformationally restricted dinucleotide monomers and oligonucleotidesLACKEY JEREMY·Filed 2011·Application pending·0 cites
- 2638US2011282044A1Process for synthesizing oligonucleotide phosphate derivativesMANOHARAN MUTHIAH·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ivan Zlatev files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →